These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 23745549)

  • 1. Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.
    Stem MS; Gardner TW
    Curr Med Chem; 2013; 20(26):3241-50. PubMed ID: 23745549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives.
    Simó R; Hernández C;
    Trends Endocrinol Metab; 2014 Jan; 25(1):23-33. PubMed ID: 24183659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.
    Narayanan SP; Shosha E; D Palani C
    Pharmacol Res; 2019 Sep; 147():104299. PubMed ID: 31207342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurovascular regulation in diabetic retinopathy and emerging therapies.
    Ji L; Tian H; Webster KA; Li W
    Cell Mol Life Sci; 2021 Aug; 78(16):5977-5985. PubMed ID: 34230991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.
    Moran EP; Wang Z; Chen J; Sapieha P; Smith LE; Ma JX
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H738-49. PubMed ID: 27473938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin replacement: a new strategy for treating diabetic retinopathy.
    Hernández C; Simó R;
    Curr Med Chem; 2013; 20(26):3251-7. PubMed ID: 23745546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new view of diabetic retinopathy: a neurodegenerative disease of the eye.
    Barber AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):283-90. PubMed ID: 12657367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in cell therapies using stem cells/progenitors as a novel approach for neurovascular repair of the diabetic retina.
    Lechner J; Medina RJ; Lois N; Stitt AW
    Stem Cell Res Ther; 2022 Jul; 13(1):388. PubMed ID: 35907890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic Retinopathy: Pathophysiology and Treatments.
    Wang W; Lo ACY
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy.
    Rolev KD; Shu XS; Ying Y
    Neuropharmacology; 2021 Apr; 187():108498. PubMed ID: 33582150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications.
    Semeraro F; Morescalchi F; Cancarini A; Russo A; Rezzola S; Costagliola C
    Diabetes Metab; 2019 Dec; 45(6):517-527. PubMed ID: 31005756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis.
    Mudaliar S; Hupfeld C; Chao DL
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1235-1244. PubMed ID: 33512450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic control of early neurodegenerative events in diabetic retinopathy by the histone deacetylase SIRT6.
    Zorrilla-Zubilete MA; Yeste A; Quintana FJ; Toiber D; Mostoslavsky R; Silberman DM
    J Neurochem; 2018 Jan; 144(2):128-138. PubMed ID: 29049850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.
    Zafar S; Sachdeva M; Frankfort BJ; Channa R
    Curr Diab Rep; 2019 Feb; 19(4):17. PubMed ID: 30806815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegeneration in diabetic retinopathy: Potential for novel therapies.
    Barber AJ; Baccouche B
    Vision Res; 2017 Oct; 139():82-92. PubMed ID: 28988945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegeneration in diabetic retinopathy: does it really matter?
    Simó R; Stitt AW; Gardner TW
    Diabetologia; 2018 Sep; 61(9):1902-1912. PubMed ID: 30030554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy.
    Jindal V
    Mol Neurobiol; 2015; 51(3):878-84. PubMed ID: 24826918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinational Approaches Targeting Neurodegeneration, Oxidative Stress, and Inflammation in the Treatment of Diabetic Retinopathy.
    Chalke SD; Kale PP
    Curr Drug Targets; 2021; 22(16):1810-1824. PubMed ID: 33745432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic retinopathy: neuron protection as a therapeutic target.
    Zhang X; Wang N; Barile GR; Bao S; Gillies M
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1525-9. PubMed ID: 23506699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications.
    Simó R; Hernández C;
    Br J Ophthalmol; 2012 Oct; 96(10):1285-90. PubMed ID: 22887976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.